We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Orchid Chemicals, a medium-sized Indian drugmaker, has signed an
agreement with US-based firm Alpharma to produce and supply generic products
to be exclusively marketed by Alpharma in the US and Europe.
Indian drugmaker Ranbaxy has announced that it has gained tentative
US FDA approval for its generic version of Aricept (donepezil hydrochloride)
at the 5mg and 10mg dosages.
Leading Israeli generics maker Teva has announced that the US FDA
has given final approval for its ANDA on the company's methylprednisolone acetate
injectable suspension.
Brazil's health ministry has announced that it is to invest BRL80mn
(US$30.39mn) on research into new medicines to combat viral and bacterial infections.
France's sanofi-aventis has announced that the date of its litigation
against Canada's Apotex and Indian generic drugmaker Dr. Reddy's over blockbuster
blood thinner Plavix has been put back to April 8.
The vaccines unit of UK-based drug major GlaxoSmithKline, GSK Biologicals,
is to conduct clinical trials in India for its new vaccine for rotavirus, a
highly virulent cause of potentially fatal gastroenteritis in young children,
mainly in developing countries.
Japanese pharmaceuticals producer Fujisawa has awarded Canada's Cardiome
a US$6mn milestone payment, following completion of the first Phase III trial
on promising anti-arrhythmia compound RSD1235.